Home - Products - Cell Cycle/DNA Damage - GPR - 2-(pentylsulfanyl)pyrimidine-4,6-diol

2-(pentylsulfanyl)pyrimidine-4,6-diol

CAS No. 489403-70-5

2-(pentylsulfanyl)pyrimidine-4,6-diol( —— )

Catalog No. M28439 CAS No. 489403-70-5

2-(pentylsulfanyl)pyrimidine-4,6-diol is a novel GRP84 agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 116 In Stock
10MG 174 In Stock
25MG 288 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-(pentylsulfanyl)pyrimidine-4,6-diol
  • Note
    Research use only, not for human use.
  • Brief Description
    2-(pentylsulfanyl)pyrimidine-4,6-diol is a novel GRP84 agonist.
  • Description
    2-(pentylsulfanyl)pyrimidine-4,6-diol is a novel GRP84 agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    20S proteasome
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    489403-70-5
  • Formula Weight
    214.28
  • Molecular Formula
    C9H14N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCSc1nc(O)cc(O)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • hGPR91 antagonist 1

    hGPR91 antagonist 1 is a potent and selective hGPR91 antagonist (IC50: 7 μM).GPR91, a 7TM G-Protein-Coupled Receptor, has been recently deorphanized with succinic acid as its endogenous ligand.?Current literature indicates that GPR91 plays role in various pathophysiology including renal hypertension, autoimmune disease and retinal angiogenesis.?

  • TUG-499

    TUG-499 is a selective free fatty acid receptor 1 (FFAR1 or GPR40) agonist (EC50: 7.39).

  • cangrelor tetrasodiu...

    Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.cangrelor, a non-sepesific GPR17 antagonist, alleviates pulmonary fibrosis partly by inhibiting macrophage inflammation in mice.